Preclinical CRO Market Intelligence Report - Global Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Preclinical CRO Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Preclinical CRO Market is projected to reach USD 8,517.42 million by 2027 from USD 4,925.16 million in 2021, at a CAGR 9.55% during the forecast period.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

The report on preclinical CRO identifies key attributes about the customer to define the potential market and identify different needs across the industry.

Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience.

This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

Report Findings

• The Americas Preclinical CRO Market size was estimated at USD 1,838.41 million in 2021, is expected to reach USD 1,978.98 million in 2022, and is projected to grow at a CAGR of 9.03% to reach USD 3,088.30 million by 2027.
• The Asia-Pacific Preclinical CRO Market size was estimated at USD 1,360.33 million in 2021, is expected to reach USD 1,526.29 million in 2022, and is projected to grow at a CAGR of 10.51% to reach USD 2,478.27 million by 2027.
• The Europe, Middle East & Africa Preclinical CRO Market size was estimated at USD 1,726.41 million in 2021, is expected to reach USD 1,874.68 million in 2022, and is projected to grow at a CAGR of 9.34% to reach USD 2,950.84 million by 2027.

Company Usability Profiles:

• Atuka Inc.
• CATO SMS
• Celerion
• Charles River Laboratories International, Inc.
• Emergo
• Ethica Group
• Eurofins Scientific
• ICON PLC
• Inotiv, Inc.
• Laboratory Corporation of America, Inc.
• Medpace, Inc.
• PharmaCircle LLC
• PPD Inc.
• SCiAN Services
• Shanghai Medicilon Inc.
• Syneos Health, Inc.
• Syreon Corporation
• Veristat LLC
• Vimta Labs Limited
• WuXi AppTec, Inc.
• ZM Company

Market Segmentation & Coverage:

Services:

• Bioanalysis and DMPK Studies
• Toxicology Testing

End-user:

• Biopharmaceutical Companies
• Government and Academic Institutes
• Medical Device Companies

Application:

• Cardiovascular Diseases
• Central Nervous System Disorders
• Diabetes
• Immunological Disorders
• Infectious Diseases
• Oncology
• Respiratory Diseases

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • Massachusetts
    • Minnesota
    • New Jersey
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

For more information about this report visit https://www.researchandmarkets.com/r/vhwedr